Bear Mountain Capital’s Pfizer PFE Stock Holding History

Bear Mountain Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$552	Buy	23 +1	+5%	+$26	﹤0.01%	158
2026 Q1	$617	Hold	22	–	–	﹤0.01%	146
2025 Q4	$571	Sell	22 -213	-91%	-$5.37K	﹤0.01%	150
2025 Q3	$5.83K	Buy	235 +14	+6%	+$346	﹤0.01%	119
2025 Q2	$5.42K	Sell	221 -17	-7%	-$396	﹤0.01%	117
2025 Q1	$5.67K	Buy	238 +217	+1,033%	+$5.68K	﹤0.01%	114
2024 Q4	$545	Buy	21 +1	+5%	+$27	﹤0.01%	147
2024 Q3	$597	Hold	20	–	–	﹤0.01%	141
2024 Q2	$578	Buy	+20	New	+$551	﹤0.01%	148

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Bear Mountain Capital's PFE Position: Q2 2026 in Review

Bear Mountain Capital increased its Pfizer (PFE) stake by 4.5% in Q2 2026, buying an estimated $26 and bringing the position to 23 shares worth $552. The position accounts for ﹤0.01% of the portfolio, ranked #158.

Bear Mountain Capital first reported a position in PFE in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.83K in Q3 2025. 1,179 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Bear Mountain Capital held 23 shares of Pfizer worth $552 as of Q2 2026.
Bear Mountain Capital bought 1 Pfizer share in Q2 2026, an estimated $26.
Pfizer made up ﹤0.01% of Bear Mountain Capital's portfolio in Q2 2026, its #158 holding.
Bear Mountain Capital first reported a position in Pfizer in Q2 2024 and has held it in 9 quarters since.
Bear Mountain Capital's Pfizer position peaked at $5.83K in Q3 2025.
1,179 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bear Mountain Capital's 13F filing for Q2 2026, filed 20 Jul 2026.